Related Experiment Video
Updated: May 19, 2026
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
A distinct Smoothened mutation causes severe cerebellar developmental defects and medulloblastoma in a novel
Joyoti Dey1, Sally Ditzler, Sue E Knoblaugh
1Molecular and Cellular Biology Program, University of Washington, Seattle, Washington, USA.
Abstract:
Deregulated developmental processes in the cerebellum cause medulloblastoma, the most common pediatric brain malignancy. About 25 to 30% of cases are caused by mutations increasing the activity of the Sonic hedgehog (Shh) pathway, a critical mitogen in cerebellar development. The proto-oncogene Smoothened (Smo) is a key transducer of the Shh pathway. Activating mutations in Smo that lead to constitutive activity of the Shh pathway have been identified in human medulloblastoma. To understand the developmental and oncogenic effects of two closely positioned point mutations in Smo, we characterized NeuroD2-SmoA2 mice and compared them to NeuroD2-SmoA1 mice. While both SmoA1 and SmoA2 transgenes cause medulloblastoma with similar frequencies and timing, SmoA2 mice have severe aberrations in cerebellar development, whereas SmoA1 mice are largely normal during development. Intriguingly, neurologic function, as measured by specific tests, is normal in the SmoA2 mice despite extensive cerebellar dysplasia. We demonstrate how two nearly contiguous point mutations in the same domain of the encoded Smo protein can produce striking phenotypic differences in cerebellar development and organization in mice.
Insights
Two point mutations in the Sonic hedgehog (Shh) pathway gene Smoothened (Smo) cause medulloblastoma. SmoA2 mutations severely disrupt cerebellar development, while SmoA1 mutations do not, despite similar tumor formation.
Area of Science:
- Neuroscience
- Developmental Biology
- Oncology
Background:
- Medulloblastoma, a common pediatric brain cancer, arises from deregulated cerebellar development.
- Mutations in the Sonic hedgehog (Shh) pathway, particularly in the Smoothened (Smo) gene, drive 25-30% of medulloblastoma cases.
- Activating mutations in Smo lead to constitutive Shh pathway activity, promoting tumor growth.
Purpose of the Study:
- To investigate the distinct developmental and oncogenic effects of two closely positioned point mutations in the Smo gene.
- To compare the phenotypes of NeuroD2-SmoA2 and NeuroD2-SmoA1 mouse models.
Main Methods:
- Generation and characterization of NeuroD2-SmoA2 and NeuroD2-SmoA1 mouse models.
- Assessment of medulloblastoma incidence and timing.
- Evaluation of cerebellar development and organization.
- Neurologic function testing.
Main Results:
- Both SmoA1 and SmoA2 transgenes induced medulloblastoma with similar frequency and timing.
- SmoA2 mice exhibited severe cerebellar developmental aberrations (dysplasia).
- SmoA1 mice showed largely normal cerebellar development.
- Despite cerebellar dysplasia, SmoA2 mice maintained normal neurologic function.
Conclusions:
- Two nearly contiguous point mutations in the Smo gene can lead to dramatically different outcomes in cerebellar development.
- The precise location and nature of Smo mutations significantly impact cerebellar organization and phenotype, independent of tumor formation.
- Further research is needed to understand the mechanisms underlying these differential effects on development and function.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:16In-vitro Mutagenesis